---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-042203"
form_type: "8-K"
ticker: "RBOT"
cik: "0001812173"
company_name: "Vicarious Surgical Inc."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T17:23:31.947892+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Vicarious Surgical Q1 2025: GAAP net loss $15.4M; FY cash burn guided ~$50M

## Summary
- GAAP net loss $15.4M ($2.60/shr) vs $17.0M ($2.90) Q1 2024; adjusted net loss $15.3M ($2.58/shr).
- Operating expenses $15.7M, down 2% YoY; R&D $9.4M, G&A $5.3M, S&M $1.0M.
- Cash and investments $37.4M at March 31, 2025; Q1 cash burn $11.7M.
- Full-year 2025 cash burn guidance approximately $50 million.
- CEO says company is 'just a few quarters away' from first clinical patients.

## SEC filing metadata
- accession: 0001213900-25-042203
- form_type: 8-K
- ticker: RBOT
- cik: 0001812173
- company_name: Vicarious Surgical Inc.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812173/000121390025042203/0001213900-25-042203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812173/000121390025042203/ea0241839-8k_vicarious.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-042203
- JSON: https://secwatch.observer/filing/0001213900-25-042203.json
- Plain text: https://secwatch.observer/filing/0001213900-25-042203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.